These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22868228)

  • 1. N-1-Alkyl-2-oxo-2-aryl amides as novel antagonists of the TRPA1 receptor.
    Vallin KS; Sterky KJ; Nyman E; Bernström J; From R; Linde C; Minidis AB; Nolting A; Närhi K; Santangelo EM; Sehgelmeble FW; Sohn D; Strindlund J; Weigelt D
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5485-92. PubMed ID: 22868228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrahydro-β-carboline derivatives targeting fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channels.
    Ortar G; De Petrocellis L; Moriello AS; Allarà M; Morera E; Nalli M; Di Marzo V
    Bioorg Med Chem Lett; 2013 Jan; 23(1):138-42. PubMed ID: 23206861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained TRPA1 activation in vivo.
    Koivisto A
    Acta Physiol (Oxf); 2012 Feb; 204(2):248-54. PubMed ID: 21518269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of TRPA1 channels by the fatty acid amide hydrolase inhibitor 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597).
    Niforatos W; Zhang XF; Lake MR; Walter KA; Neelands T; Holzman TF; Scott VE; Faltynek CR; Moreland RB; Chen J
    Mol Pharmacol; 2007 May; 71(5):1209-16. PubMed ID: 17314320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor.
    Defalco J; Steiger D; Gustafson A; Emerling DE; Kelly MG; Duncton MA
    Bioorg Med Chem Lett; 2010 Jan; 20(1):276-9. PubMed ID: 19945872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands.
    Morera E; De Petrocellis L; Morera L; Moriello AS; Ligresti A; Nalli M; Woodward DF; Di Marzo V; Ortar G
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6806-9. PubMed ID: 19875281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists.
    Gijsen HJ; Berthelot D; De Cleyn MA; Geuens I; Brône B; Mercken M
    Bioorg Med Chem Lett; 2012 Jan; 22(2):797-800. PubMed ID: 22222037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel azabenzofuran TRPA1 antagonists as in vivo tools.
    Copeland KW; Boezio AA; Cheung E; Lee J; Olivieri P; Schenkel LB; Wan Q; Wang W; Wells MC; Youngblood B; Gavva NR; Lehto SG; Geuns-Meyer S
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3464-8. PubMed ID: 24953819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation dependent expression of TRPA1 and TRPM8 channels in IMR-32 human neuroblastoma cells.
    Louhivuori LM; Bart G; Larsson KP; Louhivuori V; Näsman J; Nordström T; Koivisto AP; Akerman KE
    J Cell Physiol; 2009 Oct; 221(1):67-74. PubMed ID: 19507192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of TRPA1 by farnesyl thiosalicylic acid.
    Maher M; Ao H; Banke T; Nasser N; Wu NT; Breitenbucher JG; Chaplan SR; Wickenden AD
    Mol Pharmacol; 2008 Apr; 73(4):1225-34. PubMed ID: 18171730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonists.
    Chen J; Lake MR; Sabet RS; Niforatos W; Pratt SD; Cassar SC; Xu J; Gopalakrishnan S; Pereda-Lopez A; Gopalakrishnan M; Holzman TF; Moreland RB; Walter KA; Faltynek CR; Warrior U; Scott VE
    J Biomol Screen; 2007 Feb; 12(1):61-9. PubMed ID: 17099245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the biology and medicinal chemistry of TRPA1.
    Rech JC; Eckert WA; Maher MP; Banke T; Bhattacharya A; Wickenden AD
    Future Med Chem; 2010 May; 2(5):843-58. PubMed ID: 21426205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a series of aryl-N-(3-(alkylamino)-5-(trifluoromethyl)phenyl)benzamides as TRPA1 antagonists.
    Laliberté S; Vallée F; Fournier PA; Bedard L; Labrecque J; Albert JS
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3204-6. PubMed ID: 24880903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced activation of the transient receptor potential channel TRPA1 by ajoene, an allicin derivative.
    Yassaka RT; Inagaki H; Fujino T; Nakatani K; Kubo T
    Neurosci Res; 2010 Jan; 66(1):99-105. PubMed ID: 19808063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NPPB structure-specifically activates TRPA1 channels.
    Liu K; Samuel M; Ho M; Harrison RK; Paslay JW
    Biochem Pharmacol; 2010 Jul; 80(1):113-21. PubMed ID: 20226176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Amino-4-arylthiazole compounds as TRPA1 antagonists (WO 2012085662): a patent evaluation.
    De Petrocellis L; Schiano Moriello A
    Expert Opin Ther Pat; 2013 Jan; 23(1):119-47. PubMed ID: 23126422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dilated TRPA1 channel pore state is blocked by amiloride and analogues.
    Banke TG
    Brain Res; 2011 Mar; 1381():21-30. PubMed ID: 21241666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
    Nakao S; Mabuchi M; Wang S; Kogure Y; Shimizu T; Noguchi K; Tanaka A; Dai Y
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3167-3172. PubMed ID: 28576617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
    Gijsen HJ; Berthelot D; Zaja M; Brône B; Geuens I; Mercken M
    J Med Chem; 2010 Oct; 53(19):7011-20. PubMed ID: 20806939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRPA1 modulators in preclinical development.
    Viana F; Ferrer-Montiel A
    Expert Opin Ther Pat; 2009 Dec; 19(12):1787-99. PubMed ID: 19939193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.